Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sánchez de la Torre M[au]:

Search results

Items: 1 to 50 of 63

1.

Soluble PD-L1 is a potential biomarker of cutaneous melanoma aggressiveness and metastasis in obstructive sleep apnoea patients.

Cubillos-Zapata C, Martínez-García MÁ, Campos-Rodríguez F, Sánchez de la Torre M, Nagore E, Martorell-Calatayud A, Hernández Blasco L, Chiner Vives E, Abad-Capa J, Montserrat JM, Cabriada-Nuño V, Cano-Pumarega I, Corral-Peñafiel J, Diaz-Cambriles T, Mediano O, Somoza-González M, Dalmau-Arias J, Almendros I, Farré R, López-Collazo E, Gozal D, García-Río F; Spanish Sleep Network.

Eur Respir J. 2019 Jan 31;53(2). pii: 1801298. doi: 10.1183/13993003.01298-2018. Print 2019 Feb.

PMID:
30487198
2.

Normotensive patients with obstructive sleep apnoea: changes in 24-h ambulatory blood pressure monitoring with continuous positive airway pressure treatment.

Sapiña-Beltrán E, Santamaria-Martos F, Benítez I, Torres G, Masa JF, Sánchez-de-la-Torre M, Barbé F, Dalmases M.

J Hypertens. 2018 Sep 17. doi: 10.1097/HJH.0000000000001934. [Epub ahead of print]

PMID:
30234772
3.

Comparative analysis of predictive methods for early assessment of compliance with continuous positive airway pressure therapy.

Rafael-Palou X, Turino C, Steblin A, Sánchez-de-la-Torre M, Barbé F, Vargiu E.

BMC Med Inform Decis Mak. 2018 Sep 18;18(1):81. doi: 10.1186/s12911-018-0657-z.

4.

Lung function impairment is not associated with the severity of acute coronary syndrome but is associated with a shorter stay in the coronary care unit.

Casas-Méndez F, Sánchez-de-la-Torre A, Valls J, Sánchez-de-la-Torre M, Abad J, Duran-Cantolla J, Cabriada V, Masa JF, Teran J, Castella G, Worner F, Barbé F.

J Thorac Dis. 2018 Jul;10(7):4220-4229. doi: 10.21037/jtd.2018.06.134.

5.

Erectile dysfunction in obstructive sleep apnea patients: A randomized trial on the effects of Continuous Positive Airway Pressure (CPAP).

Pascual M, de Batlle J, Barbé F, Castro-Grattoni AL, Auguet JM, Pascual L, Vilà M, Cortijo A, Sánchez-de-la-Torre M.

PLoS One. 2018 Aug 8;13(8):e0201930. doi: 10.1371/journal.pone.0201930. eCollection 2018.

6.

Response.

Soler X, Sánchez-de-la-Torre A, Sánchez-de-la-Torre M.

Chest. 2018 Aug;154(2):453. doi: 10.1016/j.chest.2018.04.030. No abstract available.

PMID:
30080506
7.

Management of obstructive sleep apnoea in a primary care vs sleep unit setting: a randomised controlled trial.

Tarraubella N, Sánchez-de-la-Torre M, Nadal N, De Batlle J, Benítez I, Cortijo A, Urgelés MC, Sanchez V, Lorente I, Lavega MM, Fuentes A, Clotet J, Llort L, Vilo L, Juni MC, Juarez A, Gracia M, Castro-Grattoni AL, Pascual L, Minguez O, Masa JF, Barbé F.

Thorax. 2018 Dec;73(12):1152-1160. doi: 10.1136/thoraxjnl-2017-211237. Epub 2018 Jul 31.

PMID:
30064993
8.

Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients.

Martinez-Garcia MA, Campos-Rodriguez F, Nagore E, Martorell A, Rodriguez-Peralto JL, Riveiro-Falkenbach E, Hernandez L, Bañuls J, Arias E, Ortiz P, Cabriada V, Gardeazabal J, Montserrat JM, Carrera C, Corral J, Masa JF, de Terreros JG, Abad J, Boada A, Mediano O, de Eusebio E, Chiner E, Landete P, Mayos M, Fortuño A, Barbé F, Sánchez de la Torre M, Sanchez de la Torre A, Cano I, Gonzalez C, Pérez-Gil A, Gómez-García T, Cullen D, Somoza M, Formigón M, Aizpuru F, Navarro C, Selma-Ferrer MJ, Garcia-Ortega A, de Unamuno B, Almendros I, Farré R, Gozal D; Spanish Sleep Network.

Chest. 2018 Dec;154(6):1348-1358. doi: 10.1016/j.chest.2018.07.015. Epub 2018 Jul 27.

PMID:
30059679
9.

Respiratory Disorders During Sleep: A New Dimension for 2018.

Montserrat JM, Sánchez-de-la Torre M, Terán J, Egea C.

Arch Bronconeumol. 2018 Jul 24. pii: S0300-2896(18)30202-3. doi: 10.1016/j.arbres.2018.05.012. [Epub ahead of print] English, Spanish. No abstract available.

10.

The Use of Precision Medicine to Manage Obstructive Sleep Apnea Treatment in Patients with Resistant Hypertension: Current Evidence and Future Directions.

Sapiña E, Torres G, Barbé F, Sánchez-de-la-Torre M.

Curr Hypertens Rep. 2018 Jun 8;20(7):60. doi: 10.1007/s11906-018-0853-3. Review.

PMID:
29884918
11.

Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea.

Suarez-Giron MC, Castro-Grattoni A, Torres M, Farré R, Barbé F, Sánchez-de-la-Torre M, Gozal D, Picado C, Montserrat JM, Almendros I.

Front Physiol. 2018 May 24;9:600. doi: 10.3389/fphys.2018.00600. eCollection 2018.

12.

Rationale and Methodology of the SARAH Trial: Long-Term Cardiovascular Outcomes in Patients With Resistant Hypertension and Obstructive Sleep Apnea.

Sapiña-Beltrán E, Torres G, Martínez-Alonso M, Sánchez-de-la-Torre M, Franch M, Bravo C, Masa JF, Felez M, Fortuna-Gutierrez AM, Abad J, García-Río F, Drager LF, Lee Chi-Hang R, Martínez-García MÁ, Barbé F, Dalmases M.

Arch Bronconeumol. 2018 Oct;54(10):518-523. doi: 10.1016/j.arbres.2018.03.002. Epub 2018 May 23. English, Spanish.

13.

Mortality in Patients Treated with Continuous Positive Airway Pressure at the Population Level.

de Batlle J, Bertran S, Turino C, Escarrabill J, Sánchez-de-la-Torre M, Woehrle H, Barbé F.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1486-1488. doi: 10.1164/rccm.201709-1889LE. No abstract available.

PMID:
29782808
14.

Assessing sleep health in a European population: Results of the Catalan Health Survey 2015.

Dalmases M, Benítez ID, Mas A, Garcia-Codina O, Medina-Bustos A, Escarrabill J, Saltó E, Buysse DJ, Roure N, Sánchez-de-la-Torre M, Rué M, Barbé F, de Batlle J.

PLoS One. 2018 Apr 18;13(4):e0194495. doi: 10.1371/journal.pone.0194495. eCollection 2018.

15.

Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea.

Santamaria-Martos F, Benítez I, Girón C, Barbé F, Martínez-García MA, Hernández L, Montserrat JM, Nagore E, Martorell A, Campos-Rodriguez F, Corral J, Cabriada V, Abad J, Mediano O, Troncoso MF, Cano-Pumarega I, Fortuna Gutierrez AM, Diaz-Cambriles T, Somoza-Gonzalez M, Almendros I, Farre R, Gozal D, Sánchez-de-la-Torre M; Spanish Sleep Network.

Eur Respir J. 2018 Mar 15;51(3). pii: 1701885. doi: 10.1183/13993003.01885-2017. Print 2018 Mar.

PMID:
29519923
16.

Blood pressure response to CPAP treatment in subjects with obstructive sleep apnoea: the predictive value of 24-h ambulatory blood pressure monitoring.

Castro-Grattoni AL, Torres G, Martínez-Alonso M, Barbé F, Turino C, Sánchez-de-la-Torre A, Cortijo A, Duran-Cantolla J, Egea C, Cao G, Sánchez-de-la-Torre M.

Eur Respir J. 2017 Oct 5;50(4). pii: 1700651. doi: 10.1183/13993003.00651-2017. Print 2017 Oct.

PMID:
28982776
17.

Characterization of the CPAP-treated patient population in Catalonia.

Turino C, Bertran S, Gavaldá R, Teixidó I, Woehrle H, Rué M, Solsona F, Escarrabill J, Colls C, García-Altés A, de Batlle J, Sánchez de-la-Torre M, Barbé F.

PLoS One. 2017 Sep 21;12(9):e0185191. doi: 10.1371/journal.pone.0185191. eCollection 2017.

18.

Predictors of CPAP compliance in different clinical settings: primary care versus sleep unit.

Nadal N, de Batlle J, Barbé F, Marsal JR, Sánchez-de-la-Torre A, Tarraubella N, Lavega M, Sánchez-de-la-Torre M.

Sleep Breath. 2018 Mar;22(1):157-163. doi: 10.1007/s11325-017-1549-7. Epub 2017 Sep 1.

PMID:
28865067
19.

Cardiac Troponin Values in Patients With Acute Coronary Syndrome and Sleep Apnea: A Pilot Study.

Sánchez-de-la-Torre A, Soler X, Barbé F, Florés M, Maisel A, Malhotra A, Rue M, Bertran S, Aldomá A, Worner F, Valls J, Lee CH, Turino C, Galera E, de Batlle J, Sánchez-de-la-Torre M; Spanish Sleep Network(∗).

Chest. 2018 Feb;153(2):329-338. doi: 10.1016/j.chest.2017.06.046. Epub 2017 Jul 20.

20.

Cell Death Biomarkers and Obstructive Sleep Apnea: Implications in the Acute Coronary Syndrome.

Bauça JM, Yañez A, Fueyo L, de la Peña M, Pierola J, Sánchez-de-la-Torre A, Mediano O, Cabriada-Nuño V, Masdeu MJ, Teran-Santos J, Duran-Cantolla J, Masa JF, Abad J, Sanchez-de-la-Torre M, Barbé F, Barceló A; Spanish Sleep Network.

Sleep. 2017 May 1;40(5). doi: 10.1093/sleep/zsx049.

PMID:
28419383
21.

Predictors of obstructive sleep apnoea in patients admitted for acute coronary syndrome.

de Batlle J, Turino C, Sánchez-de-la-Torre A, Abad J, Duran-Cantolla J, McEvoy RD, Antic NA, Mediano O, Cabriada V, Masdeu MJ, Teran J, Valls J, Barbé F, Sánchez-de-la-Torre M; Spanish Sleep Group.

Eur Respir J. 2017 Mar 15;49(3). pii: 1600550. doi: 10.1183/13993003.00550-2016. Print 2017 Mar.

22.

Management of continuous positive airway pressure treatment compliance using telemonitoring in obstructive sleep apnoea.

Turino C, de Batlle J, Woehrle H, Mayoral A, Castro-Grattoni AL, Gómez S, Dalmases M, Sánchez-de-la-Torre M, Barbé F.

Eur Respir J. 2017 Feb 8;49(2). pii: 1601128. doi: 10.1183/13993003.01128-2016. Print 2017 Feb.

23.

GESAP trial rationale and methodology: management of patients with suspected obstructive sleep apnea in primary care units compared to sleep units.

Tarraubella N, de Batlle J, Nadal N, Castro-Grattoni AL, Gómez S, Sánchez-de-la-Torre M, Barbé F.

NPJ Prim Care Respir Med. 2017 Feb 7;27(1):8. doi: 10.1038/s41533-016-0010-x. No abstract available.

24.

Gut epithelial barrier markers in patients with obstructive sleep apnea.

Barceló A, Esquinas C, Robles J, Piérola J, De la Peña M, Aguilar I, Morell-Garcia D, Alonso A, Toledo N, Sánchez-de la Torre M, Barbé F.

Sleep Med. 2016 Oct;26:12-15. doi: 10.1016/j.sleep.2016.01.019. Epub 2016 Sep 28.

25.

Central Sleep Apnoea Is Related to the Severity and Short-Term Prognosis of Acute Coronary Syndrome.

Florés M, de Batlle J, Sánchez-de-la-Torre A, Sánchez-de-la-Torre M, Aldomá A, Worner F, Galera E, Seminario A, Torres G, Dalmases M, Montserrat JM, Garmendia O, Barbé F; Spanish Sleep Group.

PLoS One. 2016 Nov 23;11(11):e0167031. doi: 10.1371/journal.pone.0167031. eCollection 2016.

26.

[Personalized medicine in sleep apnea: Towards a new paradigm of comprehensive disease management].

Sánchez-de-la-Torre M, Barbé F.

Med Clin (Barc). 2016 Nov 18;147(10):444-446. doi: 10.1016/j.medcli.2016.09.002. Epub 2016 Oct 15. Spanish. No abstract available.

PMID:
27751511
27.

Effect of Patient Sex on the Severity of Coronary Artery Disease in Patients with Newly Diagnosis of Obstructive Sleep Apnoea Admitted by an Acute Coronary Syndrome.

Sánchez-de-la-Torre A, Abad J, Durán-Cantolla J, Mediano O, Cabriada V, Masdeu MJ, Terán J, Masa JF, de la Peña M, Aldomá A, Worner F, Valls J, Barbé F, Sánchez-de-la-Torre M; Spanish Sleep Group.

PLoS One. 2016 Jul 14;11(7):e0159207. doi: 10.1371/journal.pone.0159207. eCollection 2016.

28.

Precision medicine: A modern odyssey.

Torres G, Sánchez-de-la-Torre M, Barbé F.

Arch Bronconeumol. 2016 Sep;52(9):455-6. doi: 10.1016/j.arbres.2016.02.004. Epub 2016 Apr 14. English, Spanish. No abstract available.

29.

Association between Obstructive Sleep Apnea and Community-Acquired Pneumonia.

Chiner E, Llombart M, Valls J, Pastor E, Sancho-Chust JN, Andreu AL, Sánchez-de-la-Torre M, Barbé F.

PLoS One. 2016 Apr 6;11(4):e0152749. doi: 10.1371/journal.pone.0152749. eCollection 2016.

30.

Impact of Obstructive Sleep Apnea on the Levels of Placental Growth Factor (PlGF) and Their Value for Predicting Short-Term Adverse Outcomes in Patients with Acute Coronary Syndrome.

Barcelo A, Bauça JM, Yañez A, Fueyo L, Gomez C, de la Peña M, Pierola J, Rodriguez A, Sanchez-de-la-Torre M, Abad J, Mediano O, Amilibia J, Masdeu MJ, Teran J, Montserrat JM, Mayos M, Sanchez-de-la-Torre A, Barbé F; Spanish Sleep Group.

PLoS One. 2016 Mar 1;11(3):e0147686. doi: 10.1371/journal.pone.0147686. eCollection 2016.

31.

Long-term adherence to continuous positive airway pressure therapy in non-sleepy sleep apnea patients.

Campos-Rodriguez F, Martinez-Alonso M, Sanchez-de-la-Torre M, Barbe F; Spanish Sleep Network.

Sleep Med. 2016 Jan;17:1-6. doi: 10.1016/j.sleep.2015.07.038. Epub 2015 Oct 20.

PMID:
26847966
32.

Reply: Precision Medicine, Obstructive Sleep Apnea, and Refractory Hypertension.

Sánchez-de-la-Torre M, Barbé F.

J Am Coll Cardiol. 2016 Feb 9;67(5):602. doi: 10.1016/j.jacc.2015.10.088. No abstract available.

33.

Intermittent Hypoxia-Induced Cardiovascular Remodeling Is Reversed by Normoxia in a Mouse Model of Sleep Apnea.

Castro-Grattoni AL, Alvarez-Buvé R, Torres M, Farré R, Montserrat JM, Dalmases M, Almendros I, Barbé F, Sánchez-de-la-Torre M.

Chest. 2016 Jun;149(6):1400-8. doi: 10.1016/j.chest.2015.11.010. Epub 2016 Jan 13.

PMID:
26836908
34.

What treatment wins in the battle against sleepiness?

Sánchez-de-la-Torre M, Barbé F.

Lancet Respir Med. 2015 Nov;3(11):828-9. doi: 10.1016/S2213-2600(15)00455-5. Epub 2015 Oct 26. No abstract available.

PMID:
26510882
35.

Precision Medicine in Patients With Resistant Hypertension and Obstructive Sleep Apnea: Blood Pressure Response to Continuous Positive Airway Pressure Treatment.

Sánchez-de-la-Torre M, Khalyfa A, Sánchez-de-la-Torre A, Martinez-Alonso M, Martinez-García MÁ, Barceló A, Lloberes P, Campos-Rodriguez F, Capote F, Diaz-de-Atauri MJ, Somoza M, González M, Masa JF, Gozal D, Barbé F; Spanish Sleep Network.

J Am Coll Cardiol. 2015 Sep 1;66(9):1023-32. doi: 10.1016/j.jacc.2015.06.1315.

36.

Reply: To PMID 25747162.

Muniesa MJ, Sánchez-de-la-Torre M, Huerva V, Barbé F.

Cornea. 2015 Oct;34(10):e31. doi: 10.1097/ICO.0000000000000560. No abstract available.

PMID:
26226475
37.

Use of Ambulatory Blood Pressure Monitoring for the Screening of Obstructive Sleep Apnea.

Torres G, Sánchez-de-la-Torre M, Martínez-Alonso M, Gómez S, Sacristán O, Cabau J, Barbé F.

J Clin Hypertens (Greenwich). 2015 Oct;17(10):802-9. doi: 10.1111/jch.12619. Epub 2015 Jul 22.

38.

Relationship Between OSA and Hypertension.

Torres G, Sánchez-de-la-Torre M, Barbé F.

Chest. 2015 Sep;148(3):824-832. doi: 10.1378/chest.15-0136. Review.

PMID:
25879807
39.

Role of primary care in the follow-up of patients with obstructive sleep apnoea undergoing CPAP treatment: a randomised controlled trial.

Sánchez-de-la-Torre M, Nadal N, Cortijo A, Masa JF, Duran-Cantolla J, Valls J, Serra S, Sánchez-de-la-Torre A, Gracia M, Ferrer F, Lorente I, Urgeles MC, Alonso T, Fuentes A, Armengol F, Lumbierres M, Vázquez-Polo FJ, Barbé F; Respiratory Medicine Research Group.

Thorax. 2015 Apr;70(4):346-52. doi: 10.1136/thoraxjnl-2014-206287.

PMID:
25766689
40.

Corneal biomechanical properties in floppy eyelid syndrome.

Muniesa M, March A, Sánchez-de-la-Torre M, Huerva V, Jurjo C, Barbé F, Barbé Illa F.

Cornea. 2015 May;34(5):521-4. doi: 10.1097/ICO.0000000000000396. Erratum in: Cornea. 2015 Jun;34(6):e19. Muniesa Royo, MaJesús [corrected to Muniesa, MaJesús]; March de Ribot, Ana [corrected to March, Ana]; Huerva Escanilla, Valetin [corrected to Huerva, Valetín]; Jurjo Campo, Carmen [corrected to Jurjo, Carmen]; Barbé Illa, Ferran [corrected to Barbé, F.

PMID:
25747162
41.

Effect of obstructive sleep apnoea on severity and short-term prognosis of acute coronary syndrome.

Barbé F, Sánchez-de-la-Torre A, Abad J, Durán-Cantolla J, Mediano O, Amilibia J, Masdeu MJ, Florés M, Barceló A, de la Peña M, Aldomá A, Worner F, Valls J, Castellà G, Sánchez-de-la-Torre M; Spanish Sleep Network.

Eur Respir J. 2015 Feb;45(2):419-27. doi: 10.1183/09031936.00071714. Epub 2015 Jan 8.

42.

Impact of obstructive sleep apnea on the 24-h metabolic hormone profile.

Sánchez-de-la-Torre M, Barceló A, Piérola J, de la Peña M, Valls J, Barbé F.

Sleep Med. 2014 Jun;15(6):625-30. doi: 10.1016/j.sleep.2014.03.007. Epub 2014 Apr 15.

PMID:
24856648
43.

Effect of CPAP treatment on plasma high sensitivity troponin levels in patients with obstructive sleep apnea.

Barceló A, Esquinas C, Bauçà JM, Piérola J, de la Peña M, Arqué M, Sánchez-de-la-Torre M, Alonso-Fernández A, Barbé F.

Respir Med. 2014 Jul;108(7):1060-3. doi: 10.1016/j.rmed.2014.04.005. Epub 2014 Apr 23.

44.

Vitamin-D pathway genes and HIV-1 disease progression in injection drug users.

Laplana M, Sánchez-de-la-Torre M, Puig T, Caruz A, Fibla J.

Gene. 2014 Jul 15;545(1):163-9. doi: 10.1016/j.gene.2014.04.035. Epub 2014 Apr 21.

PMID:
24768180
45.

Blood pressure improvement with continuous positive airway pressure is independent of obstructive sleep apnea severity.

Bakker JP, Edwards BA, Gautam SP, Montesi SB, Durán-Cantolla J, Aizpuru F, Barbé F, Sánchez-de-la-Torre M, Malhotra A.

J Clin Sleep Med. 2014 Apr 15;10(4):365-9. doi: 10.5664/jcsm.3604. Erratum in: J Clin Sleep Med. 2014;10(6):711. Barandiarán, Felipe Aizpuru [corrected to Aizpuru, Felipe].

46.

Impact of OSA on biological markers in morbid obesity and metabolic syndrome.

Salord N, Gasa M, Mayos M, Fortuna-Gutierrez AM, Montserrat JM, Sánchez-de-la-Torre M, Barceló A, Barbé F, Vilarrasa N, Monasterio C.

J Clin Sleep Med. 2014 Mar 15;10(3):263-70. doi: 10.5664/jcsm.3524.

47.

Obstructive sleep apnoea and cardiovascular disease.

Sánchez-de-la-Torre M, Campos-Rodriguez F, Barbé F.

Lancet Respir Med. 2013 Mar;1(1):61-72. doi: 10.1016/S2213-2600(12)70051-6. Epub 2012 Nov 6. Review.

PMID:
24321805
48.

Rationale and methodology of the impact of continuous positive airway pressure on patients with ACS and nonsleepy OSA: the ISAACC Trial.

Esquinas C, Sánchez-de-la Torre M, Aldomá A, Florés M, Martínez M, Barceló A, Barbé F; Spanish Sleep Network.

Clin Cardiol. 2013 Sep;36(9):495-501. doi: 10.1002/clc.22166. Epub 2013 Jul 10.

49.

Floppy eyelid syndrome as an indicator of the presence of glaucoma in patients with obstructive sleep apnea.

Muniesa M, Sánchez-de-la-Torre M, Huerva V, Lumbierres M, Barbé F.

J Glaucoma. 2014 Jan;23(1):e81-5. doi: 10.1097/IJG.0b013e31829da19f.

PMID:
23807350
50.

The relationship between floppy eyelid syndrome and obstructive sleep apnoea.

Muniesa MJ, Huerva V, Sánchez-de-la-Torre M, Martínez M, Jurjo C, Barbé F.

Br J Ophthalmol. 2013 Nov;97(11):1387-90. doi: 10.1136/bjophthalmol-2012-303051. Epub 2013 Apr 12.

PMID:
23584721

Supplemental Content

Loading ...
Support Center